§ 13F · FUND PROFILE
SILVERARC CAPITAL MANAGEMENT, LLC.
AUM · $962M (13F)Positions · 73Turnover · n/a · Q2Filed · Aug 13, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$260M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | ASND | ASCENDIS PHARMA A/S | 206K | $55M | 5.7% | NEW |
| 2 | CELC | CELCUITY INC | 501K | $52M | 5.4% | +40% |
| 3 | COGT | COGENT BIOSCIENCES INC | 1.28M | $50M | 5.2% | −3% |
| 4 | URGN | UROGEN PHARMA LTD | 1.30M | $48M | 5.0% | −13% |
| 5 | IMNM | IMMUNOME INC | 2.02M | $43M | 4.4% | +9% |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | 390K | $38M | 4.0% | −40% |
| 7 | RYTM | RHYTHM PHARMACEUTICALS INC | 311K | $35M | 3.6% | +2% |
| 8 | ORKA | ORUKA THERAPEUTICS INC | 353K | $34M | 3.5% | +134% |
| 9 | GLUE | MONTE ROSA THERAPEUTICS INC | 1.11M | $27M | 2.8% | −45% |
| 10 | SNDX | SYNDAX PHARMACEUTICALS INC | 1.21M | $27M | 2.8% | +37% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE SILVERARC SIGNAL
AC read
SILVERARC CAPITAL MANAGEMENT, LLC is a Other fund managing $962 million in assets. The fund runs a portfolio of 73 positions.
Read the full dossier →